Clinical use of lopinavir/ritonavir in a salvage therapy setting-Reference-Cited by-同舟云学术

Clinical use of lopinavir/ritonavir in a salvage therapy setting

Published:2002-10 Issue:15 Volume:16 Page:2081-2083
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Boffito Marta,Arnaudo Isabella,Raiteri Riccardo,Bonora Stefano,Sinicco Alessandro,Di Garbo Antonio,Reynolds Helen E,Hoggard Patrick G,Back David J,Perri Giovanni Di

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference3 articles.

1. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

2. Identification of Genotypic Changes in Human Immunodeficiency Virus Protease That Correlate with Reduced Susceptibility to the Protease Inhibitor Lopinavir among Viral Isolates from Protease Inhibitor-Experienced Patients

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis;Drug Metabolism and Pharmacokinetics;2022-12

2. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design;Molecules;2021-12-05

3. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy;Biomedicine & Pharmacotherapy;2021-06

4. The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review;Coronaviruses;2021-05

5. Pharmacological treatments of COVID-19;Pharmacological Reports;2020-08-20